Publication | Closed Access
Assessment of JC virus DNA in blood and urine from natalizumab‐treated patients
102
Citations
15
References
2010
Year
Measuring JCV DNA in blood or urine with currently available methods is unlikely to be useful for predicting PML risk in natalizumab-treated MS patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1